In AML, IGF2BP2 stabilizes protein arginine methyltransferase 6 (PRMT6) and subsequently downregulates the expression of the lipid transporter major facilitator superfamily domain containing 2A (MFSD2A), thereby maintaining the function of leukemia stem cells.414. This evidence concerns the gene IGF2BP2 and leukemia.